A citation-based method for searching scientific literature

Rían W Manville, Jennifer van der Horst, Kaitlyn E Redford, Benjamin B Katz, Thomas A Jepps, Geoffrey W Abbott. Proc Natl Acad Sci U S A 2019
Times Cited: 15







List of co-cited articles
82 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


6
100

A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns.
N A Singh, C Charlier, D Stauffer, B R DuPont, R J Leach, R Melis, G M Ronen, I Bjerre, T Quattlebaum, J V Murphy,[...]. Nat Genet 1998
876
40

Direct neurotransmitter activation of voltage-gated potassium channels.
Rían W Manville, Maria Papanikolaou, Geoffrey W Abbott. Nat Commun 2018
39
40

KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel.
H S Wang, Z Pan, W Shi, B S Brown, R S Wymore, I S Cohen, J E Dixon, D McKinnon. Science 1998
915
40

A potassium channel mutation in neonatal human epilepsy.
C Biervert, B C Schroeder, C Kubisch, S F Berkovic, P Propping, T J Jentsch, O K Steinlein. Science 1998
795
33


Distribution of M-channel subunits KCNQ2 and KCNQ3 in rat hippocampus.
Felicia Klinger, Georgianna Gould, Stefan Boehm, Mark S Shapiro. Neuroimage 2011
36
33

Molecular expression and pharmacological identification of a role for K(v)7 channels in murine vascular reactivity.
S Y M Yeung, V Pucovský, J D Moffatt, L Saldanha, M Schwake, S Ohya, I A Greenwood. Br J Pharmacol 2007
149
33

M-Channel Activation Contributes to the Anticonvulsant Action of the Ketone Body β-Hydroxybutyrate.
Rían W Manville, Maria Papanikolaou, Geoffrey W Abbott. J Pharmacol Exp Ther 2020
8
50



Aloperine executes antitumor effects against multiple myeloma through dual apoptotic mechanisms.
He Wang, Shu Yang, Hong Zhou, Mingna Sun, Lingran Du, Minyan Wei, Meixia Luo, Jingzhu Huang, Hongzhu Deng, Yinghong Feng,[...]. J Hematol Oncol 2015
34
26

Molecular determinants of KCNQ (Kv7) K+ channel sensitivity to the anticonvulsant retigabine.
Anne Schenzer, Thomas Friedrich, Michael Pusch, Paul Saftig, Thomas J Jentsch, Joachim Grötzinger, Michael Schwake. J Neurosci 2005
191
26

Fast docking using the CHARMM force field with EADock DSS.
Aurélien Grosdidier, Vincent Zoete, Olivier Michielin. J Comput Chem 2011
222
26

SwissDock, a protein-small molecule docking web service based on EADock DSS.
Aurélien Grosdidier, Vincent Zoete, Olivier Michielin. Nucleic Acids Res 2011
745
26

The KCNQ5 potassium channel mediates a component of the afterhyperpolarization current in mouse hippocampus.
Anastassios V Tzingounis, Matthias Heidenreich, Tatjana Kharkovets, Guillermo Spitzmaul, Henrik S Jensen, Roger A Nicoll, Thomas J Jentsch. Proc Natl Acad Sci U S A 2010
71
26


The new anticonvulsant retigabine favors voltage-dependent opening of the Kv7.2 (KCNQ2) channel by binding to its activation gate.
Thomas V Wuttke, Guiscard Seebohm, Sigrid Bail, Snezana Maljevic, Holger Lerche. Mol Pharmacol 2005
194
20

Refinement of the binding site and mode of action of the anticonvulsant Retigabine on KCNQ K+ channels.
Wienke Lange, Jan Geissendörfer, Anne Schenzer, Joachim Grötzinger, Guiscard Seebohm, Thomas Friedrich, Michael Schwake. Mol Pharmacol 2009
94
20

Gabapentin Is a Potent Activator of KCNQ3 and KCNQ5 Potassium Channels.
Rían W Manville, Geoffrey W Abbott. Mol Pharmacol 2018
27
20

Atomic basis for therapeutic activation of neuronal potassium channels.
Robin Y Kim, Michael C Yau, Jason D Galpin, Guiscard Seebohm, Christopher A Ahern, Stephan A Pless, Harley T Kurata. Nat Commun 2015
48
20

Aloperine induces apoptosis and inhibits invasion in MG-63 and U2OS human osteosarcoma cells.
Shao Chen, Zhicheng Jin, Li Dai, Hongqiang Wu, Jieke Wang, Long Wang, Zongwei Zhou, Lianghui Yang, Weiyang Gao. Biomed Pharmacother 2018
20
20

Protective effects of aloperine on monocrotaline-induced pulmonary hypertension in rats.
Fan Wu, Yinju Hao, Jiamei Yang, Wanxia Yao, Yanping Xu, Lin Yan, Yang Niu, Tao Sun, Jianqiang Yu, Ru Zhou. Biomed Pharmacother 2017
19
20


KCNQ4, a novel potassium channel expressed in sensory outer hair cells, is mutated in dominant deafness.
C Kubisch, B C Schroeder, T Friedrich, B Lütjohann, A El-Amraoui, S Marlin, C Petit, T J Jentsch. Cell 1999
615
20

A constitutively open potassium channel formed by KCNQ1 and KCNE3.
B C Schroeder, S Waldegger, S Fehr, M Bleich, R Warth, R Greger, T J Jentsch. Nature 2000
384
20

The Natural Plant Product Rottlerin Activates Kv7.1/KCNE1 Channels.
Veronika Matschke, Ilaria Piccini, Janina Schubert, Eva Wrobel, Florian Lang, Johann Matschke, Elsie Amedonu, Sven G Meuth, Timo Strünker, Nathalie Strutz-Seebohm,[...]. Cell Physiol Biochem 2016
10
30

Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant retigabine.
M J Main, J E Cryan, J R Dupere, B Cox, J J Clare, S A Burbidge. Mol Pharmacol 2000
225
20

Neuro-protective effects of aloperine in an Alzheimer's disease cellular model.
Jing Zhao, Ge Zhang, Min Li, Qinghua Luo, Yu Leng, Xu Liu. Biomed Pharmacother 2018
13
23

Aloperine in combination with therapeutic adenoviral vector synergistically suppressed the growth of non-small cell lung cancer.
Tahir Muhammad, Ali Sakhawat, Aamir Ali Khan, Hua Huang, Haroon Rashid Khan, Yinghui Huang, Juan Wang. J Cancer Res Clin Oncol 2020
8
37



KCNQ1, KCNE2, and Na+-coupled solute transporters form reciprocally regulating complexes that affect neuronal excitability.
Geoffrey W Abbott, Kwok-Keung Tai, Daniel L Neverisky, Alex Hansler, Zhaoyang Hu, Torsten K Roepke, Daniel J Lerner, Qiuying Chen, Li Liu, Bojana Zupan,[...]. Sci Signal 2014
47
13

Human brain beta-hydroxybutyrate and lactate increase in fasting-induced ketosis.
J W Pan, T L Rothman, K L Behar, D T Stein, H P Hetherington. J Cereb Blood Flow Metab 2000
91
13

Teamwork: Ion channels and transporters join forces in the brain.
Rían W Manville, Geoffrey W Abbott. Neuropharmacology 2019
5
40

Three mechanisms underlie KCNQ2/3 heteromeric potassium M-channel potentiation.
Ainhoa Etxeberria, Irene Santana-Castro, M Paz Regalado, Paloma Aivar, Alvaro Villarroel. J Neurosci 2004
61
13

SMIT1 Modifies KCNQ Channel Function and Pharmacology by Physical Interaction with the Pore.
Rían W Manville, Daniel L Neverisky, Geoffrey W Abbott. Biophys J 2017
14
14


Expression and function of the K+ channel KCNQ genes in human arteries.
Fu Liang Ng, Alison J Davis, Thomas A Jepps, Maksym I Harhun, Shuk Yin Yeung, Andrew Wan, Marcus Reddy, David Melville, Antonio Nardi, Teck K Khong,[...]. Br J Pharmacol 2011
99
13

Fundamental role for the KCNE4 ancillary subunit in Kv7.4 regulation of arterial tone.
Thomas A Jepps, Georgina Carr, Pia R Lundegaard, Søren-Peter Olesen, Iain A Greenwood. J Physiol 2015
45
13


Kcne4 Deletion Sex-Dependently Alters Vascular Reactivity.
Geoffrey W Abbott, Thomas A Jepps. J Vasc Res 2016
21
13

KCNQ-Encoded Potassium Channels as Therapeutic Targets.
Vincenzo Barrese, Jennifer B Stott, Iain A Greenwood. Annu Rev Pharmacol Toxicol 2018
51
13


Discovery and evolution of aloperine derivatives as a new family of HCV inhibitors with novel mechanism.
Xin Zhang, Xiao-Qin Lv, Sheng Tang, Lin Mei, Ying-Hong Li, Jing-Pu Zhang, Jian-Dong Jiang, Zong-Gen Peng, Dan-Qing Song. Eur J Med Chem 2018
14
14



Structure of KCNE1 and implications for how it modulates the KCNQ1 potassium channel.
Congbao Kang, Changlin Tian, Frank D Sönnichsen, Jarrod A Smith, Jens Meiler, Alfred L George, Carlos G Vanoye, Hak Jun Kim, Charles R Sanders. Biochemistry 2008
155
13


Structural Basis of Human KCNQ1 Modulation and Gating.
Ji Sun, Roderick MacKinnon. Cell 2020
68
13


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.